Combivent Interactions
There are 490 drugs known to interact with Combivent (albuterol/ipratropium), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 19 are major, 451 are moderate, and 20 are minor.
- View all 490 medications that may interact with Combivent
- View Combivent alcohol/food interactions (2)
- View Combivent disease interactions (8)
Most frequently checked interactions
View interaction reports for Combivent (albuterol / ipratropium) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- amlodipine
- aspirin
- atorvastatin
- budesonide
- ceftriaxone
- clarithromycin
- enoxaparin
- furosemide
- gabapentin
- Lasix (furosemide)
- levofloxacin
- levothyroxine
- lisinopril
- losartan
- metformin
- methylprednisolone
- metoprolol
- omeprazole
- potassium chloride
- prednisone
- ranitidine
- simvastatin
- Singulair (montelukast)
- Spiriva (tiotropium)
- spironolactone
- Symbicort (budesonide / formoterol)
- tramadol
- Vitamin D3 (cholecalciferol)
Combivent alcohol/food interactions
There are 2 alcohol/food interactions with Combivent (albuterol / ipratropium).
Combivent disease interactions
There are 8 disease interactions with Combivent (albuterol / ipratropium) which include:
- cardiovascular
- diabetes
- hypokalemia
- seizures
- anticholinergic effects
- tachycardia
- renal/liver
- renal dysfunction
More about Combivent (albuterol / ipratropium)
- Combivent consumer information
- Compare alternatives
- Reviews (23)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bronchodilator combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.